Stay updated with breaking news from Anges Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vasomune Therapeutics and AnGes drug candidate AV-001 Receives Positive Recommendation from the IDSMB for AV001-004 Phase 2a Study
DUBLIN--(BUSINESS WIRE)--The "COVID-19 - Competitive Landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "COVID-19 Competitive landscape 2023" report provides comprehensive insights about 400+ companies and 500+ drugs in COVID-19 Competitive landscape. It covers the therapeutics assessme...
/PRNewswire/ -- DelveInsight's Atherosclerotic Cardiovascular Disease Market Insights report includes a comprehensive understanding of current treatment...
/PRNewswire/ -- DelveInsight's Peripheral Artery Disease Market Insights report provides the current and forecast market analysis, individual leading...
Resources prioritized to advance avexitide in hyperinsulinemic hypoglycemia indicationsActive discussions underway with potential partners to advance late-stage virology programsReduction in... -Today at 04:06 pm- MarketScreener